Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

14
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
14
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

7
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
7
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

1.9K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.9K
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

37
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
37
Antibiotic Selection00:57

Antibiotic Selection

61.9K
Overview
61.9K
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

7
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These...
7

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cytosolic EZH2-IMPDH2 complexes regulate melanoma progression and metastasis via GTP.

Molecular cell·2026
Same author

DUSP11 is an RNA triphosphatase that limits PspCas13b activity by destabilizing gRNA abundance in mammalian cells.

Nucleic acids research·2026
Same author

A microRNA generated via lysosomal processing of ribosomal RNA suppresses proinflammatory responses.

Life science alliance·2026
Same author

Structural and molecular basis of specialized translation mediated by the ribosome mRNA-binding channel.

Nature communications·2026
Same author

Purification of ribosomes from human embryonic stem (hES) cells for high-resolution Cryo-EM structural studies.

Frontiers in molecular biosciences·2026
Same author

Accessory subunits of PRC2 mimic H3K27me3 to restrict the spread of Polycomb domains.

Molecular cell·2026

Related Experiment Video

Updated: Mar 18, 2026

Author Spotlight: Exploring Cytoskeletal Dynamics to Unveil Novel Antibiotics Through Innovative Cell-Based Assays
05:57

Author Spotlight: Exploring Cytoskeletal Dynamics to Unveil Novel Antibiotics Through Innovative Cell-Based Assays

Published on: April 26, 2024

1.4K

Ribosomal Antibiotics: Contemporary Challenges.

Tamar Auerbach-Nevo1, David Baram2, Anat Bashan3

  • 1Department of Structural Biology, Weizmann Institute, Rehovot 76100, Israel. tauerba@its.jnj.com.

Antibiotics (Basel, Switzerland)
|July 2, 2016
PubMed
Summary
This summary is machine-generated.

The study proposes a conceptual revision in antibiotic development, moving from broad-spectrum to pathogen-specific antibiotics. This approach addresses multi-drug resistance and considers microbiome and environmental impacts.

Keywords:
microbiomemulti-drug resistancenovel degradable antibioticsspecies-specific antibiotics susceptibility

More Related Videos

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

5.6K
Atomic Force Microscopy Combined with Infrared Spectroscopy as a Tool to Probe Single Bacterium Chemistry
08:51

Atomic Force Microscopy Combined with Infrared Spectroscopy as a Tool to Probe Single Bacterium Chemistry

Published on: September 15, 2020

4.7K

Related Experiment Videos

Last Updated: Mar 18, 2026

Author Spotlight: Exploring Cytoskeletal Dynamics to Unveil Novel Antibiotics Through Innovative Cell-Based Assays
05:57

Author Spotlight: Exploring Cytoskeletal Dynamics to Unveil Novel Antibiotics Through Innovative Cell-Based Assays

Published on: April 26, 2024

1.4K
Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

5.6K
Atomic Force Microscopy Combined with Infrared Spectroscopy as a Tool to Probe Single Bacterium Chemistry
08:51

Atomic Force Microscopy Combined with Infrared Spectroscopy as a Tool to Probe Single Bacterium Chemistry

Published on: September 15, 2020

4.7K

Area of Science:

  • Microbiology
  • Pharmacology
  • Environmental Science

Background:

  • Antibiotic resistance is a growing global threat, with slow progress in developing new drugs.
  • Current antibiotics often have broad-spectrum activity, impacting beneficial bacteria and the environment.
  • Existing strategies for antibiotic development require substantial conceptual revision.

Purpose of the Study:

  • To highlight contemporary issues in antibiotic development, including the preference for broad-range antibiotics.
  • To emphasize the need to consider microbiome alterations and ecological aspects of antibiotic usage.
  • To explore advances in designing novel, environmentally friendly, pathogen-specific antibiotics.

Main Methods:

  • Review of current challenges in antibiotic development.
  • Analysis of the impact of antibiotics on microbiome populations.
  • Exploration of recent advances in identifying species-specific structural motifs for novel antibiotic design.

Main Results:

  • Identification of species-specific structural motifs for novel antibiotic design.
  • Potential for creating environmentally friendly, degradable antibiotics.
  • Shift towards "pathogen-specific antibiotics" as an alternative to broad-range agents.

Conclusions:

  • A conceptual shift towards pathogen-specific antibiotics is necessary to combat multi-drug resistance.
  • Developing novel antibiotics requires accelerated discovery of unique species motifs and improved pathogen identification.
  • Future antibiotic development should integrate microbiome and environmental considerations.